FdaApplication

ANDA 078555

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCHARTWELL RX SCIENCES LLC
application_typeANDA
approval_date2013-11-22

Products (3)

ProductActive ingredientStrengthDosage form
REPAGLINIDEREPAGLINIDE1MGTABLET;ORAL
REPAGLINIDEREPAGLINIDE2MGTABLET;ORAL
REPAGLINIDEREPAGLINIDE0.5MGTABLET;ORAL

3 products